Mode
Text Size
Log in / Sign up

Tele-robot-assisted prostatectomy achieves 100% technical success in small case seriesRemote Robot Prostate Surgery Shows Promise in Early Data

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider tele-robot-assisted prostatectomy as feasible in select high-volume centers, but interpret cautiously due to limited data.

This meta-analysis pooled data from small case series to evaluate the feasibility of tele-robot-assisted prostatectomy in patients undergoing prostatectomy. The primary outcomes included technical success rate, complications, operative time, estimated blood loss, and postoperative hospital stay. The analysis found a 100% technical success rate (80/80 procedures), with no severe complications (Clavien-Dindo ≥ Grade III) reported (95% CI: 0.0%-4.3%). The overall complication rate was 19.4% (95% CI: 7.1%-36.8%, I² = 71.2%), all of which were Clavien-Dindo Grade I. Operative time averaged 190.41 minutes (95% CI: 167.19-213.62), estimated blood loss was 72.25 mL (95% CI: 50.76-93.73), and postoperative hospital stay averaged 5.16 days (95% CI: 4.25-6.08). Network latency parameters were reported as mean 160.58 ms, max 208.58 ms, min 160.73 ms, and round-trip 97.39 ms. The authors acknowledge significant limitations, including a limited evidence base from small case series, short-term follow-up, and the preliminary nature of the feasibility data. They emphasize that remote prostatectomy should be restricted to high-volume centers with established robotic surgery programs, robust network infrastructure, and well-defined emergency protocols. This evidence is not definitive for established safety, and further research is needed before broader adoption.

How this fits prior evidence

This meta-analysis extends prior coverage on robotic prostatectomy by demonstrating that tele-robot-assisted prostatectomy is technically feasible, with a 100% success rate in small case series. It complements findings that single-port robotic-assisted radical prostatectomy offers comparable oncological outcomes with improved recovery, suggesting that remote surgery may further expand access. However, unlike prior evidence on salvage radiotherapy and ADT, which showed survival benefits, this analysis focuses on perioperative feasibility and does not report oncological outcomes. It also contrasts with frailty-related survival risks, as tele-robotic approaches may reduce perioperative complications, but the evidence remains preliminary.

A new analysis of early studies suggests that tele-robot-assisted prostatectomy, where a surgeon operates a robot from a distance, is technically feasible. In the 80 patients studied, the procedure was completed successfully in every case, with no severe complications reported. However, this is preliminary evidence from small case series, and the findings are not definitive proof of safety or effectiveness.

The analysis, which combined results from several small studies, found that the average operative time was about 190 minutes, estimated blood loss was about 72 mL, and the average hospital stay was about 5 days. The overall complication rate was 19.4%, but all complications were mild (Grade I on the Clavien-Dindo scale). The network latency, or delay in the remote connection, averaged around 160 milliseconds, which is within acceptable limits for surgery.

While these results are encouraging, the evidence base is limited. The studies were small, had short-term follow-up, and were not randomized trials. This means that the findings should be interpreted with caution. The analysis also noted that remote prostatectomy should only be performed in high-volume centers with established robotic surgery programs, robust network infrastructure, and well-defined emergency protocols.

For patients considering prostate cancer surgery, this research is not yet practice-changing. It suggests that remote surgery is possible, but more research is needed to confirm its safety and benefits compared to standard approaches. As always, patients should discuss their treatment options with their healthcare provider.

What this means for you:
Remote robot prostate surgery is feasible in early studies, but more research is needed before it becomes standard.

Common questions

Is remote robot prostate surgery safe?

In this analysis, no severe complications occurred, and all complications were mild. However, the evidence is preliminary and based on small studies, so safety is not yet fully established. More research is needed to confirm its safety profile.

Who might benefit from this procedure?

This procedure is for patients undergoing prostatectomy (removal of the prostate). It may be useful in situations where a specialist surgeon is not physically present. However, it is currently recommended only for high-volume centers with strong robotic programs and emergency protocols.

How does this compare to standard robot surgery?

The analysis did not directly compare tele-robot surgery to standard robot surgery. It only reported outcomes for the remote procedure. The operative time, blood loss, and hospital stay were within typical ranges, but direct comparisons are needed to know if it is better or worse.

Study Details

Study typeMeta analysis
Sample sizen = 80
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Telesurgery has emerged as an important frontier technology for overcoming geographical barriers and enabling the decentralization of high-quality medical resources. However, the evidence for tele-robot-assisted prostatectomy remains limited to small-sample case series, lacking systematic quantitative synthesis of perioperative outcomes. PubMed, Embase, Cochrane Library, and Web of Science were systematically searched from inception to July 2026. Studies reporting perioperative outcomes of tele-robot-assisted prostatectomy were included; non-remote surgeries, animal experiments, and studies from which data could not be extracted were excluded. A single-arm meta-analysis was performed using a random-effects model. Primary outcomes included technical success rate, complications, operative time, estimated blood loss, and postoperative hospital stay. Subgroup analyses were stratified by robotic system type, network type, and sample size. Methodological quality was assessed using the JBI Critical Appraisal Checklist for Case Series. Seven studies comprising 80 patients (77 radical prostatectomies, 3 simple prostatectomies) were included. The pooled technical success rate was 100% (80/80). No Clavien-Dindo ≥ Grade III complications were observed, with a pooled severe complication rate of 0.0% (95% CI: 0.0%-4.3%). Among five studies reporting prostate-specific overall complication data, the pooled overall complication rate (any grade) was 19.4% (95% CI: 7.1%-36.8%, I² = 71.2%), all Clavien-Dindo Grade I events. Pooled operative time was 190.41 min (95% CI: 167.19-213.62), estimated blood loss was 72.25 mL (95% CI: 50.76-93.73), and postoperative hospital stay was 5.16 days (95% CI: 4.25-6.08). Network latency parameters-mean latency (160.58 ms), maximum latency (208.58 ms), minimum latency (160.73 ms), and round-trip time (97.39 ms)-all remained within the established safety threshold of < 300 ms. Subgroup analysis revealed a statistically significant difference in operative time when stratified by patient volume (> 10 vs. ≤10 cases, P = 0.04), suggesting a learning curve effect as an important source of operative time heterogeneity. After stratification by network type, heterogeneity was markedly reduced in the 5G group (I² = 29.6%) while remaining very high in the fiber-optic group (I² = 93.0%), further confirming transmission distance rather than network medium as the core driver of operative time heterogeneity. All seven studies demonstrated low risk of bias (JBI score ≥ 9/10). In this first systematic review and meta-analysis of tele-robot-assisted prostatectomy-based on limited evidence from seven small case series comprising 80 patients-the procedure was associated with 100% technical success and zero high-grade complications, with operative time and blood loss comparable to published benchmarks for conventional robot-assisted prostatectomy, and network parameters consistently within established safety thresholds. Subgroup analyses suggested that the learning curve effect is an important source of operative time heterogeneity, while transmission distance may contribute to heterogeneity in operative time and network latency. However, the evidence base remains limited to small case series with short-term follow-up, and these findings should be interpreted as preliminary evidence of feasibility rather than definitive evidence of established safety. Large-scale prospective comparative studies are urgently needed to validate these findings. Remote prostatectomy should be restricted to high-volume centers with established robotic surgery programs, robust network infrastructure, and well-defined emergency protocols.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.